Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Hematology  |  Musculoskeletal  |  Oncology

Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1671) clinical trials

People with Myeloid Leukemia are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

People with Lymphoma and Leukemia are asked to participate in a research study being conducted by Long Island Jewish Medical Center.

Phase N/A

People with chronic lymphocytic leukemia are asked to participate in a research study being conducted by White Plains Hospital.

Phase N/A

People with Lymphoma and Leukemia are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

People with Relapsed/Refractory Acute Myeloid Leukemia are asked to participate in a research study being conducted by North Shore University Hospital.

Phase

A registry trial for Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease

Phase N/A

People with acute myeloid leukemia (AML) are asked to participate in a research study being conducted by North Shore University Hospital.

Phase N/A

People with Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

People with chronic lymphocytic leukemia are asked to participate in a research study being conducted by Northwell Health.

Phase N/A

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

PRIMARY OBJECTIVES: I. To assess the clinical benefit of nivolumab in T-cell lymphomas, as measured by objective response rate (ORR) within 12 cycles according to the Lugano Classification Response Criteria (2014). SECONDARY OBJECTIVES: I. To assess safety and tolerability of the regimen in this patient population. II. To assess progression-free ...

Phase